ERT’s cardiology team is available to consult and provide strategic value on study design, as well as medical and regulatory issues. With more than 70 years of combined industry and regulatory experience, the team is led by two of the most highly regarded thought leaders in the industry: ERT’s chairman and chief scientific officer Joel Morganroth, M.D., F.A.C.C. and ERT’s executive vice president and chief medical officer, Jeffrey S. Litwin, M.D. F.A.C.C.
For more information please see our website, or contact us.